Financials data is unavailable for this security.
View more
Year on year Zealand Pharma A/S grew revenues 229.65% from 103.99m to 342.79m while net income improved from a loss of 1.20bn to a smaller loss of 703.74m.
Gross margin | 90.96% |
---|---|
Net profit margin | -193.49% |
Operating margin | -198.85% |
Return on assets | -11.67% |
---|---|
Return on equity | -12.80% |
Return on investment | -12.12% |
More ▼
Cash flow in DKKView more
In 2023, cash reserves at Zealand Pharma A/S fell by 619.92m. Cash Flow from Financing totalled 907.01m or 264.60% of revenues. In addition the company used 425.67m for operations while cash used for investing totalled 1.09bn.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 132.48 |
---|---|
Tangible book value per share | 132.31 |
More ▼
Balance sheet in DKKView more
Current ratio | 35.57 |
---|---|
Quick ratio | 35.57 |
Total debt/total equity | 0.0415 |
---|---|
Total debt/total capital | 0.0399 |
More ▼